Results
Transgene Biotek Q1 FY27 Net Loss at ₹38.90 Lakh
Board approved unaudited standalone and consolidated financial results for Q1 FY27, reporting a net loss of ₹38.90 lakh.
Appointed M/s. Manisha Dubey & Associates as internal auditors for FY 2026-27 a
